These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 33367

  • 21. A critical assessment of behavioural test procedures used to analyse dopaminergic and antidopaminergic drugs.
    Nohria V.
    Methods Find Exp Clin Pharmacol; 1983; 5(6):357-64. PubMed ID: 6137599
    [No Abstract] [Full Text] [Related]

  • 22. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
    Zazpe A, Artaiz I, Innerárity A, Del Olmo E, Castro E, Labeaga L, Pazos A, Orjales A.
    Neuropharmacology; 2006 Jul; 51(1):129-40. PubMed ID: 16643965
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. In vivo microdialysis studies of striatal level of neurotransmitters after haloperidol and chlorpromazine administration.
    Kulkarni SK, Bishnoi M, Chopra K.
    Indian J Exp Biol; 2009 Feb; 47(2):91-7. PubMed ID: 19374163
    [Abstract] [Full Text] [Related]

  • 28. The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.
    Khisti RT, Deshpande LS, Chopde CT.
    Psychopharmacology (Berl); 2002 May; 161(2):120-8. PubMed ID: 11981591
    [Abstract] [Full Text] [Related]

  • 29. Inhibition of rat liver CYP2D in vitro and after 1-day and long-term exposure to neuroleptics in vivo-possible involvement of different mechanisms.
    Daniel WA, Haduch A, Wójcikowski J.
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):103-10. PubMed ID: 15572279
    [Abstract] [Full Text] [Related]

  • 30. Influence of L-5-hydroxytryptophan and DL-p-chlorophenylalanine on neurophysiological profiles of serotonin reuptake inhibitors in rabbits.
    Bo P, Patrucco M, Maurelli M, Camana C, Savoldi F.
    Farmaco Sci; 1987 Aug; 42(8):595-601. PubMed ID: 2959563
    [Abstract] [Full Text] [Related]

  • 31. [The action of neuroleptics on different types of catalepsy in rats with a genetic predisposition to catatonic reactions].
    Kolpakov VG, Nikulina EM, Alekhina TA, Gevorgian MM.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1995 Aug; 45(2):388-94. PubMed ID: 7597835
    [Abstract] [Full Text] [Related]

  • 32. Behavioral, anti-dopaminergic, and prohypnotic effects of neuroleptics during and after prolonged treatment.
    Biazzi A, Fregnan GB.
    Adv Biochem Psychopharmacol; 1980 Aug; 24():351-7. PubMed ID: 6105785
    [No Abstract] [Full Text] [Related]

  • 33. Effects of phenothiazine neuroleptics on the rate of caffeine demethylation and hydroxylation in the rat liver.
    Daniel WA, Syrek M, Ryłko Z, Kot M.
    Pol J Pharmacol; 2001 Aug; 53(6):615-21. PubMed ID: 11985335
    [Abstract] [Full Text] [Related]

  • 34. The action of neuroleptics in rats with altered catecholamine metabolism. I. The influence of MAO inhibitors on the behavioral actions of chlorpromazine, haloperidol, and thioridazine.
    Vetulani J.
    Pol J Pharmacol Pharm; 1973 Aug; 25(1):41-52. PubMed ID: 4798098
    [No Abstract] [Full Text] [Related]

  • 35. Effect of apomorphine plus 5-hydroxytryptophan on plasma prolactin levels in male rats.
    Meltzer HY, Fang VS.
    Psychopharmacol Commun; 1976 Aug; 2(3):189-98. PubMed ID: 1087036
    [Abstract] [Full Text] [Related]

  • 36. Effects of some neuroleptic drugs on aggressive behavior in isolated mice.
    Rewerski W, Kostowski W, Piechocki T.
    Acta Physiol Pol; 1979 Aug; 30(2):295-8. PubMed ID: 37694
    [Abstract] [Full Text] [Related]

  • 37. Intrathecal chlorprothixene, cis(z)-flupenthixol, chlorpromazine and fluphenazine for prolonged spinal blockades of sensory and motor functions in rats.
    Chen YW, Chu CC, Chen YC, Leung YM, Wang JJ.
    Eur J Pharmacol; 2012 Oct 15; 693(1-3):31-6. PubMed ID: 22926199
    [Abstract] [Full Text] [Related]

  • 38. Potentiation and inhibition of the amphetamine stereotypy in rats by neuroleptics and other agents.
    Lal S, Sourkes TL.
    Arch Int Pharmacodyn Ther; 1972 Oct 15; 199(2):289-301. PubMed ID: 4672248
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The influence of cerebral 5-hydroxytryptamine on catalepsy induced by brain-amine depleting neuroleptics or by cholinomimetics.
    Fuenmayor LD, Vogt M.
    Br J Pharmacol; 1979 Oct 15; 67(2):309-18. PubMed ID: 40649
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.